MedPath

Investigation for the treatment option and cost in urological cancers

Not Applicable
Conditions
rological cancers
Registration Number
JPRN-UMIN000028544
Lead Sponsor
Hirosaki University
Brief Summary

A risk score-stratified surveillance protocol has the potential to reduce over investigation during follow-up, making surveillance more cost-effective.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
426
Inclusion Criteria

Not provided

Exclusion Criteria

Urological cancer patients who do not undergo any therapy

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relationship between the treatment option and medical cost
Secondary Outcome Measures
NameTimeMethod
Optimal use of medical budget for suitable candidates
© Copyright 2025. All Rights Reserved by MedPath